(Q37831107)

24 August 2017

1 reference

title

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. (English)

1 reference

lymphoproliferative disorders

24 August 2017

1 reference

1 reference

1 reference

10

E Matutes

1 reference

24 August 2017

M C Béné

1

1 reference

24 August 2017

T Nebe

2

1 reference

24 August 2017

P Bettelheim

3

1 reference

24 August 2017

B Buldini

4

1 reference

24 August 2017

H Bumbea

5

1 reference

24 August 2017

W Kern

6

1 reference

24 August 2017

F Lacombe

7

1 reference

24 August 2017

P Lemez

8

1 reference

24 August 2017

I Marinov

9

1 reference

24 August 2017

M Maynadié

11

1 reference

24 August 2017

U Oelschlagel

12

1 reference

24 August 2017

A Orfao

13

1 reference

24 August 2017

R Schabath

14

1 reference

24 August 2017

M Solenthaler

15

1 reference

24 August 2017

G Tschurtschenthaler

16

1 reference

24 August 2017

A M Vladareanu

17

1 reference

24 August 2017

G Zini

18

1 reference

24 August 2017

G C Faure

19

1 reference

24 August 2017

A Porwit

20

1 reference

24 August 2017

21 January 2011

1 reference

24 August 2017

1 reference

24 August 2017

25

1 reference

24 August 2017

4

1 reference

24 August 2017

567-574

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.312

24 August 2017

0 references

cites work

Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Expression of cell-surface antigens in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Acute Megakaryoblastic Leukaemia: A National Clinical and Biological Study of 53 Adult and Childhood Cases by the Groupe Français d'Hématologie Cellulaire (GFHC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Diagnosis of acute basophilic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Flow cytometric immunophenotyping for hematologic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Heterogenous Expression of CD15 in Acute Lymphoblastic Leukemia: A Study of Ten Anti-CD15 Monoclonal Antibodies in 158 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Initial human myeloid/dendritic cell progenitors identified by absence of myeloperoxidase protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Antibody-based therapy of leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Morphological and immunophenotypic features of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Chronic T-cell lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

State of the Art Symposium: flow cytometry in the diagnosis of lymphoproliferative disorders by fine-needle aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Coordination of activating and inhibitory signals in natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

Receptor-directed therapy of T-cell leukemias and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Immunological classification of acute myeloblastic leukemias: relevance to patient outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Minimally differentiated erythroleukaemia (AML M6 Variant'): a rare subset of AML distinct from AML M6

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Cell surface CD43 determination improves diagnostic precision in late B-cell diseases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Immunophenotyping of angioimmunoblastic T-cell lymphomas by multiparameter flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.312

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.312

1 reference

24 August 2017

1 reference